These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 629046)

  • 21. Genetic polymorphisms in the fourth component of complement (C4) and in properdin factor B (BF) in Japanese patients with palmoplantar pustulosis.
    Torii H; Nakagawa H; Ishibashi Y; Tokunaga K; Juji T
    J Dermatol; 1992 Jun; 19(6):353-5. PubMed ID: 1401488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fourth component of complement (C4) polymorphism in human orthotopic liver transplantation.
    Wölpl A; Robin-Winn M; Pichlmayr R; Goldmann SF
    Transplantation; 1985 Aug; 40(2):154-7. PubMed ID: 3895621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine binding protein of the fourth component of complement: structural polymorphism and its linkage to the major histocompatibility complex.
    Kaidoh T; Natsuume-Sakai S; Takahashi M
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3794-8. PubMed ID: 6943584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.
    Greiner J; Weber FJ; Mauff G; Baur M
    Immunobiology; 1980; 158(1-2):134-8. PubMed ID: 6907169
    [No Abstract]   [Full Text] [Related]  

  • 25. Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.
    Schneider PM; Carroll MC; Alper CA; Rittner C; Whitehead AS; Yunis EJ; Colten HR
    J Clin Invest; 1986 Sep; 78(3):650-7. PubMed ID: 3018042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].
    Doutre MS
    Pathol Biol (Paris); 1983 Sep; 31(7):622-30. PubMed ID: 6355995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statement on the nomenclature of dog C4 allotypes.
    Doxiadis G; Schoen W; Doxiadis I; Deeg HJ; O'Neill GJ; Grosse-Wilde H
    Immunogenetics; 1987; 25(3):167-70. PubMed ID: 3557563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotyping of human complement component C4, a class-III HLA antigen.
    Sim E; Cross SJ
    Biochem J; 1986 Nov; 239(3):763-7. PubMed ID: 3103606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications.
    Lhotta K; Auinger M; Kronenberg F; Irsigler K; König P
    Diabetes Care; 1996 Jan; 19(1):53-5. PubMed ID: 8720534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.
    Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP
    Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement C4, factor B and C3 polymorphism in north India.
    Kramer J; Srivastava LM; Ferenczy E; Füst G
    Acta Microbiol Immunol Hung; 1995; 42(3):315-9. PubMed ID: 8548205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum C4 levels, Chido, Rodgers, and allotypes of C4 component of complement.
    O'Neill GJ; Dupont B
    Transplant Proc; 1979 Mar; 11(1):1102-6. PubMed ID: 452090
    [No Abstract]   [Full Text] [Related]  

  • 35. Inherited polymorphism of human C4 as revealed by desialyzation.
    Awdeh ZL; Alper CA
    Immunobiology; 1980; 158(1-2):35-41. PubMed ID: 7203518
    [No Abstract]   [Full Text] [Related]  

  • 36. Inherited incomplete deficiency of the fourth component of complement (C4) determined by a gene not linked to human histocompatibility leukocyte antigens.
    Muir WA; Hedrick S; Alper CA; Ratnoff OD; Schacter B; Wisnieski JJ
    J Clin Invest; 1984 Oct; 74(4):1509-14. PubMed ID: 6480834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between a DNA restriction fragment length polymorphism and C4A6 protein.
    Palsdottir A; Cross SJ; Edwards JH; Carroll MC
    Nature; 1983 Dec 8-14; 306(5943):615-6. PubMed ID: 6316164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma complement C4 and factor B allotypes after liver transplantation.
    Koskimies S; Lokki ML; Höckerstedt K
    Complement Inflamm; 1991; 8(5-6):257-60. PubMed ID: 1802544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family studies of complement C4 and HLA in man.
    Bruun-Petersen G; Lamm LU; Sørensen IJ; Buskjaer L; Mortensen JP
    Hum Genet; 1981; 58(3):260-7. PubMed ID: 6948763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6.
    Teisberg P; Akesson I; Olaisen B; Gedde-Dahl T; Thorsby E
    Nature; 1976 Nov; 264(5583):253-4. PubMed ID: 1088823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.